{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:11:12Z","timestamp":1780553472286,"version":"3.54.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institutes on Drug Abuse","doi-asserted-by":"crossref","award":["K02 DA032322"],"award-info":[{"award-number":["K02 DA032322"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Infections are a common cause of hospitalization for patients with opioid use disorder (OUD), and hospital admissions are rising in the context of the worsening US opioid crisis. Infectious disease (ID) physicians are frequently the first point of medical contact for these patients. In this article, we discuss the integration of evidence-based management of OUD and patient-centered care of hospitalized persons with acute injection-related infections. We describe the following components of a comprehensive approach for OUD with inpatient ID consultations: (1) how to screen for OUD; (2) how to initiate the 3 US Food and Drug Administration-approved medications for OUD (buprenorphine, methadone, and extended-release naltrexone); (3) how to manage acute pain and opioid-related conditions; and (4) how to link and integrate ID and OUD treatment after hospital discharge. These strategies reduce unplanned discharges and increase completion of recommended antimicrobial regimens.<\/jats:p>","DOI":"10.1093\/ofid\/ofz539","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T02:47:53Z","timestamp":1577155673000},"source":"Crossref","is-referenced-by-count":23,"title":["Beyond Antibiotics: A Practical Guide for the Infectious Disease Physician to Treat Opioid Use Disorder in the Setting of Associated Infectious Diseases"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1034-8679","authenticated-orcid":false,"given":"Nikhil","family":"Seval","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale School of Medicine, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Eaton","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra A","family":"Springer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale School of Medicine, New Haven, Connecticut, USA"},{"name":"Center for Interdisciplinary Research on AIDS, Yale University School of Public Health, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,12,24]]},"reference":[{"key":"2020012408163910800_CIT0001","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002-12","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"2020012408163910800_CIT0002","doi-asserted-by":"crossref","first-page":"569","DOI":"10.15585\/mmwr.mm6622a1","article-title":"Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence - North Carolina, 2010-2015","volume":"66","author":"Fleischauer","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020012408163910800_CIT0003","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"2020012408163910800_CIT0004","first-page":"Cd002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2020012408163910800_CIT0005","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","article-title":"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: results from a multisite study","volume":"56","author":"Altice","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020012408163910800_CIT0006","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/add.14012","article-title":"Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis","volume":"113","author":"Platt","year":"2018","journal-title":"Addiction"},{"key":"2020012408163910800_CIT0007","doi-asserted-by":"crossref","first-page":"ofw251","DOI":"10.1093\/ofid\/ofw251","article-title":"Infectious disease (ID) learning unit: what the ID clinician needs to know about buprenorphine treatment for opioid use disorder","volume":"4","author":"Westlake","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2020012408163910800_CIT0008","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/cid\/ciy924","article-title":"Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder","volume":"68","author":"Marks","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020012408163910800_CIT0009","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","volume":"105","author":"Jones","year":"2015","journal-title":"Am J Public Health"},{"key":"2020012408163910800_CIT0010","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz804","article-title":"Infectious complications of addiction: a call for a new subspecialty within infectious diseases","author":"Serota","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020012408163910800_CIT0011","author":"Force USPST"},{"key":"2020012408163910800_CIT0012","volume-title":"Resource Guide: Screening for Drug Use in General Medical Settings","author":"NIDA."},{"key":"2020012408163910800_CIT0013","doi-asserted-by":"crossref","first-page":"388","DOI":"10.15585\/mmwr.mm6817a3","article-title":"Drug overdose deaths involving cocaine and psychostimulants with abuse potential - United States, 2003-2017","volume":"68","author":"Kariisa","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020012408163910800_CIT0014","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1078345814557513","article-title":"Validation of a brief measure of opioid dependence: the rapid opioid dependence screen (RODS)","volume":"21","author":"Wickersham","year":"2015","journal-title":"J Correct Health Care"},{"key":"2020012408163910800_CIT0015"},{"key":"2020012408163910800_CIT0016","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1056\/NEJMra1807054","article-title":"Prevention of opioid overdose","volume":"380","author":"Babu","year":"2019","journal-title":"N Engl J Med"},{"key":"2020012408163910800_CIT0017","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMra042823","article-title":"Bacterial infections in drug users","volume":"353","author":"Gordon","year":"2005","journal-title":"N Engl J Med"},{"key":"2020012408163910800_CIT0018","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3201\/eid1901.120044","article-title":"Infections with spore-forming bacteria in persons who inject drugs, 2000-2009","volume":"19","author":"Palmateer","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2020012408163910800_CIT0019","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF01967124","article-title":"Methadone diluted with contaminated orange juice or raspberry syrup as a potential source of disseminated candidiasis in drug abusers","volume":"12","author":"Scheidegger","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020012408163910800_CIT0020","doi-asserted-by":"crossref","first-page":"ofv017","DOI":"10.1093\/ofid\/ofv017","article-title":"Disinfection of syringes contaminated with hepatitis C virus by rinsing with household products","volume":"2","author":"Binka","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"2020012408163910800_CIT0021","first-page":"595","article-title":"Bacterial infections and skin cleaning prior to injection among intravenous drug users","volume":"107","author":"Vlahov","year":"1992","journal-title":"Public Health Rep"},{"key":"2020012408163910800_CIT0022"},{"key":"2020012408163910800_CIT0023"},{"key":"2020012408163910800_CIT0024","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.drugalcdep.2009.12.008","article-title":"A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis","volume":"108","author":"Meader","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"2020012408163910800_CIT0025","volume-title":"Title 21 Code of Federal Regulations. \u00a71306.07 Administering"},{"key":"2020012408163910800_CIT0026","first-page":"Cd001333","article-title":"Oral naltrexone maintenance treatment for opioid dependence","author":"Minozzi","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2020012408163910800_CIT0027","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jamapsychiatry.2017.3206","article-title":"Effectiveness of injectable extended-release naltrexone vs daily buprenorphine-naloxone for opioid dependence: a randomized clinical noninferiority trial","volume":"74","author":"Tanum","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"2020012408163910800_CIT0028","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"key":"2020012408163910800_CIT0029","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/QAI.0000000000001634","article-title":"Extended-release naltrexone improves viral suppression among incarcerated persons living with HIV with opioid use disorders transitioning to the community: results of a double-blind, placebo-controlled randomized trial","volume":"78","author":"Springer","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020012408163910800_CIT0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsat.2019.04.008","article-title":"Experiences of care among individuals with opioid use disorder-associated endocarditis and their healthcare providers: Results from a qualitative study","volume":"102","author":"Bearnot","year":"2019","journal-title":"J Subst Abuse Treat"},{"key":"2020012408163910800_CIT0031","doi-asserted-by":"crossref","first-page":"e24459","DOI":"10.1371\/journal.pone.0024459","article-title":"Readmission rates of patients discharged against medical advice: a matched cohort study","volume":"6","author":"Choi","year":"2011","journal-title":"PLoS One"},{"key":"2020012408163910800_CIT0032","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jama.2012.234","article-title":"Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan","volume":"307","author":"Seal","year":"2012","journal-title":"JAMA"},{"key":"2020012408163910800_CIT0033","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12954-018-0241-y","article-title":"Pain as a risk factor for substance use: a qualitative study of people who use drugs in British Columbia, Canada","volume":"15","author":"Voon","year":"2018","journal-title":"Harm Reduct J"},{"key":"2020012408163910800_CIT0034","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.2105\/AJPH.2015.302885","article-title":"Leaving the hospital against medical advice among people who use illicit drugs: a systematic review","volume":"105","author":"Ti","year":"2015","journal-title":"Am J Public Health"},{"key":"2020012408163910800_CIT0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00126334-200401010-00008","article-title":"HIV-positive injection drug users who leave the hospital against medical advice: the mitigating role of methadone and social support","volume":"35","author":"Chan","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020012408163910800_CIT0036","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ADM.0000000000000487","article-title":"Tools to support hospital-based addiction care: core components, values, and activities of the improving addiction care team","volume":"13","author":"Englander","year":"2019","journal-title":"J Addict Med"},{"key":"2020012408163910800_CIT0037","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1086\/420939","article-title":"Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines","volume":"38","author":"Tice","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2020012408163910800_CIT0038","doi-asserted-by":"crossref","first-page":"ofy194","DOI":"10.1093\/ofid\/ofy194","article-title":"Outpatient parenteral antimicrobial therapy among people who inject drugs: a review of the literature","volume":"5","author":"Suzuki","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2020012408163910800_CIT0039","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijantimicag.2013.09.006","article-title":"Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade","volume":"43","author":"MacKenzie","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"2020012408163910800_CIT0040","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/cid\/ciy722","article-title":"A 9-point risk assessment for patients who inject drugs and require intravenous antibiotics: focusing inpatient resources on patients at greatest risk of ongoing drug use","volume":"68","author":"Eaton","year":"2019","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofz539\/31607458\/ofz539.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/1\/ofz539\/31955084\/ofz539.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/1\/ofz539\/31955084\/ofz539.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T01:21:49Z","timestamp":1613265709000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofz539\/5686146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,24]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofz539","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,1]]},"published":{"date-parts":[[2019,12,24]]},"article-number":"ofz539"}}